4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-046017
EVP, Drug Discovery sold 57,743 shares at an average $38.31 ($2,211,978)
- EVP, Drug Discovery gave up 7,257 shares (to pay taxes)
- EVP, Drug Discovery acquired 65,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
EMPFIELD JAMES R. · EVP, Drug Discovery
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-12 | Exercise or conversion : show line 1 in the form | +20,000 | $3.10 | $62,000 | 30,000 | D |
| 2022-08-12 | Exercise or conversion : show line 2 in the form | +45,000 | $4.75 | $213,750 | 75,000 | D |
| 2022-08-12 | Shares withheld for taxes : show line 3 in the form | −7,257 | $38.02 | $275,911 | 67,743 | D |
| 2022-08-12 | Sale : show line 4 in the form | −35,868 | $38.08 | $1,365,853 | 31,875 | D |
| 2022-08-12 | Sale : show line 5 in the form | −21,875 | $38.68 | $846,125 | 10,000 | D |
| Open-market sales · 57,743 sh · avg $38.31 · $2,211,978 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-12 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −20,000 | 0 | D |
| 2022-08-12 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −45,000 | 0 | D |
Loading xslF345X03/doc4.xml…